Related Experiment Video
Updated: Sep 12, 2025
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Exploring the Causal Relationship Between Inflammatory Bowel Disease and Bell's Palsy Based on Inflammatory Proteins:
Daofeng Fan1, Wenbao Wu2, Jiaqian Dai1
1Department of Neurology, Longyan First Hospital Affiliated to Fujian Medical University, Longyan, Fujian, China.
Background:
The relationship between inflammatory bowel disease (IBD) and Bell's palsy remains unsubstantiated. This study aims to investigate the causal relationship between IBD and Bell's palsy.
Methods:
Using the two-sample Mendelian randomization (MR) method to explore the relationship between IBD and Bell's palsy. We applied Bell's palsy summary statistics from GWAS statistics for 91 inflammatory proteins and FinnGen R10 and IBD summary statistics from the International Inflammatory Bowel Disease Genetics Consortium.
Results:
The two-sample MR study indicates a significant positive association between IBD and Bell's palsy (OR: 1.13, 95% CI [1.03-1.23], p = 0.0065) and between Crohn's disease and Bell's palsy (OR: 1.10, 95% CI [1.02-1.18], p = 0.0088). After applying Bonferroni correction, IBD remained significantly correlated with Bell's palsy. Subsequently, the causal relationship between circulating inflammatory proteins in Bell's palsy and inflammatory bowel disease samples was reevaluated. The results of the MR study on inflammatory proteins in these two diseases suggest that the C-X-C Motif Chemokine Ligand 5 (CXCL5) is a potential protective factor and interleukin_17C (IL_17C) is a risk factor for these two diseases. Conversely, Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1) is a protective factor for Bell's palsy and a risk factor for inflammatory bowel disease.
Conclusions:
The findings indicate that IBD may be a risk factor for Bell's palsy at the genetic level. CXCL5, IL_17C, and SLAMF1 are possible co-acting pathways between Bell's palsy and inflammatory bowel disease. These findings may provide new targets for the treatment of both diseases.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...